UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant To Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  March 30, 2007

CLST HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

 

0-22972

 

75-2479727

(State or other jurisdiction

 

(Commission

 

(I.R.S. Employer

of incorporation)

 

File Number)

 

Identification No.)

 

601 S. Royal Lane, Coppell, Texas

 

75019

(Address of principal executive offices)

 

(Zip Code)

 

(972) 462-2700

(Registrant’s telephone number, including area code)

CELLSTAR CORPORATION

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 




 

Item 2.01            Completion of Acquisition or Disposition of Assets.

On March 30, 2007, CLST Holdings, Inc., formerly known as CellStar Corporation (the “Company”), completed the sale (the “U.S. Sale”) of its U.S. and Miami-based Latin American operations to wholly-owned subsidiaries of Brightpoint, Inc.  Substantially all of the assets of the U.S. and Miami operations were sold for a purchase price of $88.0 million, which was reduced to $62.4 million based on a preliminary estimate of net asset adjustments.  Such reduction was pursuant to the terms and conditions of the Asset Purchase Agreement dated December 18, 2006 (the “Asset Purchase Agreement”), by and among the Company, certain affiliated parties of the Company, Brightpoint, Inc. and 2601 Metropolis Corp.  The purchase price is subject to further adjustments as the net asset adjustments and other matters set forth in the Asset Purchase Agreement are finalized.

Item 2.04            Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement.

Pursuant to the terms and conditions of the Amended and Restated Loan Agreement dated as of March 31, 2006 (the “Facility”), by and among the Company, Wells Fargo Foothill, and the other signatories thereto, and the Term Loan and Security Agreement dated as of October 31, 2006 (the “Term Loan”), by and among the Company, CaptialSource Finance LLC, and the other signatories thereto, the sale of substantially all of the Company’s assets would have accelerated the amounts due and payable under such agreements, as the assets sold were held as security for the loans.  In connection with the closing of the U.S. Sale, on March 30, 2007, the Company paid off the outstanding balances, including accrued interest, under the Facility of $13.2 million and the Term Loan of $11.9 million, using the proceeds from the U.S. Sale. An early termination fee of $0.4 million was paid in conjunction with the payoff of the Facility and will be recognized as a charge to earnings in the quarter ended May 31, 2007.

Item 5.02            Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

In connection with the closing of the U.S. Sale, on March 30, 2007, Robert Kaiser resigned from his position of President and Chief Executive Officer of the Company.  Following Mr. Kaiser’s resignation, on March 30, 2007, Michael J. Farrell was named President and Chief Executive Officer of the Company.  Mr. Farrell was appointed to serve as Treasurer and Chief Administrative Officer, positions which Mr. Farrell has retained, and Executive Vice President of Finance, on November 15, 2005. Mr. Farrell currently serves the Company pursuant to his Employment Agreement dated November 15, 2005.  Prior to joining the Company, Mr. Farrell, who is 45 years old, held various positions with Motorola, Inc., including CFO/Director of Finance for the Asia Pacific Cellular Division and CFO/Director of Finance for Motorola’s Latin America Cellular Division.  Mr. Farrell joined Motorola in 1990 and spent 14 years with the company.

Item 9.01            Financial Statements and Exhibits.

(b) Pro forma financial information.

Set forth below is a pro forma statement of operations for the fiscal year ended November 30, 2006, and a balance sheet as of November 30, 2006, reflecting the U.S. Sale.




CellStar Corporation
Unaudited Pro Forma Consolidated Balance Sheet
November 30, 2006
(in thousands)

 

CellStar
Historical

 

U.S. & Miami
Operations
Historical(a)

 

Pro Forma
Adjustments(e)

 

Total
Adjustments

 

Pro Forma
Results

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

28,632

 

 

 

 

 

64,689

(b)

 

 

64,689

 

 

 

93,321

 

 

Accounts receivable, net

 

114,335

 

 

(67,342

)

 

 

 

 

 

(67,342

)

 

 

46,993

 

 

Accounts receivable, intercompany

 

 

 

(143,706

)

 

 

143,706

(c)

 

 

 

 

 

 

 

Inventories

 

68,830

 

 

(43,454

)

 

 

 

 

 

(43,454

)

 

 

25,376

 

 

Deferred income taxes

 

917

 

 

 

 

 

 

 

 

 

 

 

917

 

 

Prepaid expenses and other current assets

 

5,847

 

 

(306

)

 

 

 

 

 

(306

)

 

 

5,541

 

 

Total current assets

 

218,561

 

 

(254,808

)

 

 

208,395

 

 

 

(46,413

)

 

 

172,148

 

 

Property, plant & equipment

 

2,510

 

 

(1,450

)

 

 

 

 

 

(1,450

)

 

 

1,060

 

 

Goodwill, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred income tax assets

 

6,655

 

 

 

 

 

 

 

 

 

 

 

6,655

 

 

Other assets

 

8,254

 

 

(192

)

 

 

 

 

 

(192

)

 

 

8,062

 

 

Total assets

 

$

235,980

 

 

(256,450

)

 

 

208,395

 

 

 

(48,055

)

 

 

187,925

 

 

Liabilities and stockholders equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes payable

 

$

33,469

 

 

 

 

 

 

 

 

 

 

 

33,469

 

 

Current portion—Term Loan

 

1,000

 

 

 

 

 

 

 

 

 

 

 

1,000

 

 

Accounts payable

 

158,365

 

 

(94,055

)

 

 

 

 

 

(94,055

)

 

 

64,310

 

 

Accounts payable—intercompany

 

 

 

(67,764

)

 

 

67,764

(c)

 

 

 

 

 

 

 

Deferred revenue

 

824

 

 

 

 

 

 

 

 

 

 

 

824

 

 

Accrued expenses

 

11,747

 

 

(5,956

)

 

 

 

 

 

(5,956

)

 

 

5,791

 

 

Income taxes payable

 

716

 

 

 

 

 

 

 

 

 

 

 

716

 

 

Minority interest

 

2,014

 

 

 

 

 

 

 

 

 

 

 

2,014

 

 

Total current liabilities

 

208,135

 

 

(167,775

)

 

 

67,764

 

 

 

(100,011

)

 

 

108,124

 

 

12% senior subordinated notes

 

1,915

 

 

 

 

 

 

 

 

 

 

 

1,915

 

 

Term Loan

 

9,160

 

 

 

 

 

 

 

 

 

 

 

9,160

 

 

Total liabilities

 

219,210

 

 

(167,775

)

 

 

67,764

 

 

 

(100,011

)

 

 

119,199

 

 

Common stock

 

212

 

 

 

 

 

 

 

 

 

 

 

212

 

 

Additional paid in capital

 

124,346

 

 

 

 

 

 

 

 

 

 

 

124,346

 

 

Treasury stock

 

(94

)

 

 

 

 

 

 

 

 

 

 

(94

)

 

Cumulative translation adjustment

 

(8,603

)

 

 

 

 

 

 

 

 

 

 

(8,603

)

 

Retained earnings

 

(99,091

)

 

(88,675

)

 

 

140,631

(d)

 

 

51,956

 

 

 

(47,135

)

 

 

 

16,770

 

 

(88,675

)

 

 

140,631

 

 

 

51,956

 

 

 

68,726

 

 

Total liabilities and stockholders’ equity

 

$

235,980

 

 

(256,450

)

 

 

208,395

 

 

 

(48,055

)

 

 

187,925

 

 


Notes:

(a)              Reflects historical financial information of the U.S. and Miami operations in the consolidated financial statements.

(b)             Reflects the estimated net proceeds from the transaction.

(c)              Reflects elimination of intercompany balances.

(d)             Reflects the estimated gain on the transaction of $52.0 million and the add back of historical retained earnings of $88.7 million.

(e)              Does not reflect any reduction in cash or debt from proceeds of the transaction. To close the U.S. sale we would be required to payoff the debt or obtain an acceptable waiver from our lenders.

53




CellStar Corporation
Unaudited Pro Forma Consolidated Statement of Operations
For the year ended November 30, 2006
(in thousands, except per share data)

 

 

CellStar
Historical

 

U.S. & Miami
Operations
Historical(a)

 

Pro Forma
Adjustments(f)

 

Total
Adjustments

 

Pro Forma
Results

 

Revenues

 

 

$

943,140

 

 

 

(599,592

)

 

 

 

 

 

(599,592

)

 

 

343,548

 

 

Cost of sales

 

 

877,754

 

 

 

(555,846

)

 

 

 

 

 

(555,846

)

 

 

321,908

 

 

Gross profit

 

 

65,386

 

 

 

(43,746

)

 

 

 

 

 

(43,746

)

 

 

21,640

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general & administrative

 

 

50,485

 

 

 

(27,195

)

 

 

 

 

 

(27,195

)

 

 

23,290

 

 

Operating income (loss)

 

 

14,901

 

 

 

(16,551

)

 

 

 

 

 

(16,551

)

 

 

(1,650

)

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(3,916

)

 

 

21

 

 

 

3,319

(b)

 

 

3,340

 

 

 

(576

)

 

Loss on sale of accounts receivable

 

 

(2,578

)

 

 

622

 

 

 

 

 

 

622

 

 

 

(1,956

)

 

Intercompany interest

 

 

 

 

 

1,345

 

 

 

(1,345

)(c)

 

 

 

 

 

 

 

Gain on retirement of 12% Senior subordinated notes  

 

 

566

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

566

 

 

Minority interest

 

 

(2,390

)

 

 

 

 

 

 

 

 

 

 

 

(2,390

)

 

Gain on sale of assets

 

 

240

 

 

 

 

 

 

 

 

 

 

 

 

240

 

 

Corporate allocation

 

 

 

 

 

9,320

 

 

 

(9,320

)(d)

 

 

 

 

 

 

 

 

Other, net

 

 

214

 

 

 

(4

)

 

 

 

 

 

(4

)

 

 

210

 

 

Total other income (expense)

 

 

(7,864

)

 

 

11,304

 

 

 

(7,346

)

 

 

3,958

 

 

 

(3,906

)

 

Income (loss) before income taxes

 

 

7,037

 

 

 

(5,247

)

 

 

(7,346

)

 

 

(12,593

)

 

 

(5,556

)

 

Provision (benefit) for income taxes

 

 

2,786

 

 

 

(1,836

)(e)

 

 

1,836

(e)

 

 

 

 

 

2,786

 

 

Income (loss) from continuing operations

 

 

$

4,251

 

 

 

(3,411

)

 

 

(9,182

)

 

 

(12,593

)

 

 

(8,342

)

 

Income (loss) per share from continuing operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

$

0.21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.41

)

 

Diluted

 

 

$

0.20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.41

)

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

20,415

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,415

 

 

Diluted

 

 

21,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,415

 

 


Notes:

(a)              Reflects historical financial information of the U.S. and Miami operations in the consolidated financial statements.

(b)             Reflects the allocation of interest expense related to the revolving credit facility and the Term Loan  associated with the U.S. and Miami operations.

(c)              Reflects adjustment for intercompany interest.

(d)             Reflects corporate allocation, including royalty fee, which would no longer be charged.

(e)              Reflects the elimination of tax expense for the purchased operations as taxes for these operations are offset with net operating losses.

(f)               The above pro forma does not reflect the estimated net gain on the transaction of $52.0 million.

 

54




Signature(s)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CELLSTAR CORPORATION

 

 

 

 

 

 

By:

 /s/ Elaine Flud Rodriguez

Date:  April 5, 2007

 

Elaine Flud Rodriguez

 

 

Senior Vice President and General Counsel